<DOC>
	<DOCNO>NCT01489722</DOCNO>
	<brief_summary>The purpose open label study evaluate safety , tolerability , pharmacokinetics , efficacy AZD1208 patient recurrent refractory Acute Myelogenous Leukemia ( AML ) . This study two part . In Part A , patient receive escalate dos identify maximum tolerate dose ( MTD ) . In Part B , efficacy maximum tolerate dose evaluate expanded group patient .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Efficacy AZD1208 Acute Myelogenous Leukemia ( AML ) Patients</brief_title>
	<detailed_description>A Phase Ia/Ib , Open-Label , Multicentre , Two-Part Study Assess Safety , Tolerability , Pharmacokinetics Efficacy AZD1208 Administered Daily Adult Patients Recurrent Refractory Acute Myelogenous Leukemia ( AML ) .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<criteria>Males female least 18 year age Patients relapse refractory Acute myelogenous leukemia ( AML ) AML secondary myelodysplastic syndrome , myeloproliferative neoplasm , chronic myelogenous leukemia Eastern Oncology Cooperative Group ( ECOG ) performance status 02 consider likely complete least 4 week therapy With exception alopecia , unresolved toxicity prior therapy great CTCAE grade 1 time start study treatment . As judged investigator , evidence severe uncontrolled systemic disease , include uncontrolled hypertension , active bleeding diatheses , active infection include hepatitis B , hepatitis C HIV . Active heart disease include myocardial infarction within last 3 month , symptomatic coronary artery disease , clinically significant arrhythmia control medication uncontrolled congestive heart failure Prior allogeneic transplant require immunosuppressive therapy ( Patients prior allogeneic transplant remain clinically stable ≥ 2 week immunosuppressive therapy , eligible ) White blood cell count ≥ 100,000/mm3 ( 100x10*9/L ) Type 1 Diabetes uncontrolled Type II Diabetes HbA1C ≥8 % fast blood glucose &gt; 160 mg/Dl ( &gt; 8.9 mmol/L ) Baseline fast total cholesterol &gt; 300 mg/dL ( &gt; 7.75 mmol/L )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Leukemia</keyword>
	<keyword>AML</keyword>
	<keyword>AZD1208</keyword>
</DOC>